Ostoros G - Search Results

1

Discrimination of clinical stages in non-small cell lung cancer patients by serum HSP27 and HSP70: a multi-institutional case-control study.

Zimmermann M, Nickl S, Lambers C, Hacker S, Mitterbauer A, Hoetzenecker K, Rozsas A, Ostoros G, Laszlo V, Hofbauer H, Renyi-Vamos F, Klepetko W, Dome B, Ankersmit HJ. Zimmermann M, et al. Among authors: ostoros g. Clin Chim Acta. 2012 Jul 11;413(13-14):1115-20. doi: 10.1016/j.cca.2012.03.008. Epub 2012 Mar 23. Clin Chim Acta. 2012. PMID: 22465083 Free article.

2

[New therapies for non-small cell lung cancer].

Ostoros G, Kovács G, Szondy K, Döme B. Ostoros G, et al. Orv Hetil. 2005 May 22;146(21):1135-41. Orv Hetil. 2005. PMID: 15991677 Review. Hungarian.

3

Lymphangiogenesis correlates with lymph node metastasis, prognosis, and angiogenic phenotype in human non-small cell lung cancer.

Renyi-Vamos F, Tovari J, Fillinger J, Timar J, Paku S, Kenessey I, Ostoros G, Agocs L, Soltesz I, Dome B. Renyi-Vamos F, et al. Among authors: ostoros g. Clin Cancer Res. 2005 Oct 15;11(20):7344-53. doi: 10.1158/1078-0432.CCR-05-1077. Clin Cancer Res. 2005. PMID: 16243806

4

Inhibition of EGFR tyrosine-kinase in NSCLC treatment: the Hungarian experience with gefitinib in the context of an expanded access programme.

Ostoros G, Harisi R, Kovacs G, Horti J, Geczi L, Szondy K, Orosz M, Ferenczi E, Ruby E, Dome B. Ostoros G, et al. Anticancer Res. 2005 Nov-Dec;25(6C):4759-62. Anticancer Res. 2005. PMID: 16334173 Free article. Clinical Trial.

5

Identification and clinical significance of circulating endothelial progenitor cells in human non-small cell lung cancer.

Dome B, Timar J, Dobos J, Meszaros L, Raso E, Paku S, Kenessey I, Ostoros G, Magyar M, Ladanyi A, Bogos K, Tovari J. Dome B, et al. Among authors: ostoros g. Cancer Res. 2006 Jul 15;66(14):7341-7. doi: 10.1158/0008-5472.CAN-05-4654. Cancer Res. 2006. PMID: 16849585 Free article.

6

[Erlotinib in the treatment of non-small cell lung cancer].

Ostoros G, Döme B. Ostoros G, et al. Magy Onkol. 2006;50(3):237-41. Epub 2006 Nov 12. Magy Onkol. 2006. PMID: 17099784 Free article. Review. Hungarian.

7

Targeting blood vessels for the treatment of non-small cell lung cancer.

Amir E, Hughes S, Blackhall F, Thatcher N, Ostoros G, Timar J, Tovari J, Kovacs G, Dome B. Amir E, et al. Among authors: ostoros g. Curr Cancer Drug Targets. 2008 Aug;8(5):392-403. doi: 10.2174/156800908785133187. Curr Cancer Drug Targets. 2008. PMID: 18690845 Review.

8

High VEGFR-3-positive circulating lymphatic/vascular endothelial progenitor cell level is associated with poor prognosis in human small cell lung cancer.

Bogos K, Renyi-Vamos F, Dobos J, Kenessey I, Tovari J, Timar J, Strausz J, Ostoros G, Klepetko W, Ankersmit HJ, Lang G, Hoda MA, Nierlich P, Dome B. Bogos K, et al. Among authors: ostoros g. Clin Cancer Res. 2009 Mar 1;15(5):1741-6. doi: 10.1158/1078-0432.CCR-08-1372. Epub 2009 Feb 24. Clin Cancer Res. 2009. PMID: 19240177

9

Antivascular agents for non-small-cell lung cancer: current status and future directions.

Amir E, Mandoky L, Blackhall F, Thatcher N, Klepetko W, Ankersmit HJ, Reza Hoda MA, Ostoros G, Dank M, Dome B. Amir E, et al. Among authors: ostoros g. Expert Opin Investig Drugs. 2009 Nov;18(11):1667-86. doi: 10.1517/13543780903336050. Expert Opin Investig Drugs. 2009. PMID: 19877762 Review.

10

[Changes in the diagnostic and therapeutic strategies of non-small cell lung cancer].

Ostoros G, Döme B, Strausz J, Tímár J. Ostoros G, et al. Magy Onkol. 2010 Jun;54(2):137-43. doi: 10.1556/MOnkol.54.2010.2.8. Magy Onkol. 2010. PMID: 20576590 Free article. Review. Hungarian.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

84 results

Search Page

Filters